Results 151 to 160 of about 15,347 (200)

Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.

open access: yesAm J Physiol Lung Cell Mol Physiol, 2017
Orcholski ME   +13 more
europepmc   +1 more source

Screening of ester-forming and hydrolyzing enzymes linked to pheromone production in Ips typographus (Linnaeus, 1758). [PDF]

open access: yesBMC Genomics
Strádal J   +7 more
europepmc   +1 more source

Cold-adapted carboxylesterases from Alcanivoracaceae active with a wide range of synthetic polyesters. [PDF]

open access: yesAppl Microbiol Biotechnol
Ma H   +6 more
europepmc   +1 more source

Integrated genomic and transcriptomic analysis reveals candidate genes underlying herbicide resistance in Sorghum. [PDF]

open access: yesBMC Plant Biol
Xing Z   +10 more
europepmc   +1 more source

Molecular cloning, purification and biochemical characterization of a novel pyrethroid-hydrolyzing carboxylesterase gene from Ochrobactrum anthropi YZ-1

open access: yesJournal of Hazardous Materials, 2012
Strain YZ-1 was isolated from activated sludge and identified as Ochrobactrum anthropi. This strain was capable of degrading pyrethroids pesticides, suggesting the presence of degrading enzymes. In the present study, a novel esterase gene pytZ was cloned
Yi Zhai, Jinlong Song
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Nomenclature for alleles of the human carboxylesterase 1 gene

Pharmacogenetics and Genomics, 2017
The carboxylesterase 1 gene (CES1) in humans encodes a hydrolase, which is implicated in the metabolism of several commonly used drugs 1. This gene is located on chromosome 16 with a highly homologous pseudogene, CES1P1, in its proximity. A duplicated segment of CES1 replaces most of CES1P1 in some individuals, thus leading to the formation of a hybrid
Rasmussen, Henrik Berg   +26 more
openaire   +3 more sources

Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation

The Journal of Pharmacology and Experimental Therapeutics, 2013
Clopidogrel pharmacotherapy is associated with substantial interindividual variability in clinical response, which can translate into an increased risk of adverse outcomes. Clopidogrel, a recognized substrate of hepatic carboxylesterase 1 (CES1), undergoes extensive hydrolytic metabolism in the liver.
Hao-Jie, Zhu   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy